Recomendaciones basadas en evidencia para el tratamiento agudo intrahospitalario de la migraña. Asociación Colombiana de Neurología

Rubio AC, Arciniegas JA, Bolanos-Lopez JE, Gonzalez FJ, Gomez D, Mesa A, et al. Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022. J Headache Pain. 2024;25(1):226. https://doi.org/10.1186/s10194-024-01918-9

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71

Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6. https://doi.org/10.1016/j.jclinepi.2010.07.015

Otto CM, Abdullah AR, Davis LL, Ferrari VA, Fremes S, Mukherjee D, et al. 2025 ACC/AHA clinical practice guidelines core principles and development process: A report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2025;152(18):e359-70. https://doi.org/10.1161/CIR.0000000000001383

(IHS) HCCotIHS. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia (2018) ;38(1):1-211

Bigal ME, Bordini CA, Speciali JG. Diclofenaco intramuscular no tratamento agudo da migrânea: um estudo duplo cego placebo controlado. Arq Neuropsiquiatr. 2002;60(2-B):410-5. https://doi.org/10.1590/S0004-282X2002000300014

Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraineheadaches in adults. Cochrane Database Syst Rev. 2012;2(2):CD008783. https://doi.org/10.1002/14651858.cd008783.pub2

Friedman BW, Garber L, Yoon A, Solorzano C, Wollowitz A, Esses D, et al. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014;82(11):976-83. https://doi.org/10.1212/wnl.0000000000000223

Seim MB, March JA, Dunn KA. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1998;5(6):573-6. https://doi.org/10.1111/j.1553-2712.1998.tb02463.x

Khazaei M, Hosseini Nejad Mir N, Yadranji Aghdam F, Taheri M, Ghafouri-Fard S. Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, and chlorpromazine for pain relief and prevention of recurrence in the migraine headache: a prospective double-blind randomized clinical trial. Neurol Sci. 2019;40(5):1029-33. https://doi.org/10.1007/s10072-019-03766-x

Engel ER, Cheng J. IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial. Neurol Sci. 2020;41(3):537-42. https://doi.org/10.1007/s10072-019-04157-y

Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies.

Headache. 2015;55(1):3-20. https://doi.org/10.1111/head.12499

Gungor F, Akyol KC, Kesapli M, Celik A, Karac A, Bozdemir MN, et al. Intravenous dexketoprofen vs placebo for migraine attack in the emergency department: a randomized, placebo-controlled trial. Cephalalgia. 2016;36(2):179-84. https://doi.org/10.1177/0333102415584604

Yavuz E, Gulacti U, Lok U, Turgut K. Intravenous metoclopramide versus dexketoprofen trometamol versus metoclopramide plus dexketoprofen trometamol in acute migraine attack in the emergency department: a randomized double-blind controlled trial. Am J Emerg Med. 2020;38(11):2254-8. https://doi.org/10.1016/j.ajem.2020.04.038

Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache: a placebo-controlled study. Cephalalgia. 2001;21(2):90-5. https://doi.org/10.1046/j.1468-2982.2001.00143.x

Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache. 2002;42(9):862-71. https://doi.org/10.1046/j.1526-4610.2002.02204.x

Tulunay FC, Ergün H, Gülmez SE, Ozbenli T, Ozmenoğlu M, Boz C, et al. The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study. Funct Neurol. 2004;19(3):197-202.

Avcu N, Doğan NÖ, Pekdemir M, Yaka E, Yilmaz S, Alyeşil C, et al. Intranasal lidocaine in acute treatment of migraine: a randomized controlled trial. Ann Emerg Med. 2017;69(6):743-51. https://doi.org/10.1016/j.annemergmed.2016.09.031

Abdelmonem H, Abdelhay HM, Abdelwadoud GT, Alhosini ANM, Ahmed AE, Mohamed SW, et al. The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. BMC Neurol. 2023;23(1):221. https://doi.org/10.1186/s12883-023-03259-7

Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S. Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache. 2008;48(3):333-40. https://doi.org/10.1111/j.1526-4610.2007.00959.x

Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, et al. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007;69(22):2038-44. https://doi.org/10.1212/01.WNL.0000281105.78936.1d

Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, et al. Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. J Emerg Med. 2011;40(4):463-8. https://doi.org/10.1016/j.jemermed.2009.08.022

Demirkaya Ş, Vural O, Dora B, Topçuoğlu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001;41(2):171-7. https://doi.org/10.1046/j.1526-4610.2001.111006171.x

Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345-53. https://doi.org/10.1046/j.1468-2982.2002.00364.x

Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med. 2001;38(6):621-7. https://doi.org/10.1067/mem.2001.119424

Shahrami A, Assarzadegan F, Hatamabadi HR, Asgarzadeh M, Sarehbandi B, Asgarzadeh S. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache. J Emerg Med. 2015;48(1):69-76. https://doi.org/10.1016/j.jemermed.2014.06.055.

Miller AC, Pfeffer B, Lawson MR, Sewell KA, King AR, Zehtabchi S. Intravenous magnesium sulfate to treat acute headaches in the emergency department: a systematic review. Headache. 2019;59(10):1674-86. https://doi.org/10.1111/head.13648

McCoy JJ, Aldy K, Arnall E, Petersen J. Treatment of headache in the emergency department: haloperidol in the acute setting (THE-HA study): a randomized clinical trial. J Emerg Med. 2020;59(1):12-20. https://doi.org/10.1016/j.jemermed.2020.04.018

Bilhimer MH, Groth ME, Holmes AK. Ketamine for migraine in the emergency department. Adv Emerg Nurs J. 2020;42(2):96-102. https://doi.org/10.1097/tme.0000000000000296

Benish T, Villalobos D, Love S, Casmaer M, Hunter CJ, Summers SM, et al. The THINK (Treatment of Headache with Intranasal Ketamine) trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide. J Emerg Med. 2019;56(3):248-57.e1. https://doi.org/10.1016/j.jemermed.2018.12.007

Zitek T, Gates M, Pitotti C, Bartlett A, Patel J, Rahbar A, et al. A comparison of headache treatment in the emergency department: prochlorperazine versus ketamine. Ann Emerg Med. 2018;71(3):369-77.e1. https://doi.org/10.1016/j.annemergmed.2017.08.063

Soleimanpour H, Ghafouri RR, Taheraghdam A, Aghamohammadi D, Negargar S, Golzari SEJ, et al. Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial. BMC Neurol. 2012;12:114. https://doi.org/10.1186/1471-2377-12-114

Moshtaghion H, Heiranizadeh N, Rahimdel A, Esmaeili A, Hashemian H, Hekmatimoghaddam S. The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical trial. Pain Pract. 2015;15(8):701-5. https://doi.org/10.1111/papr.12230

Mitra B, Roman C, Mercier E, Moloney J, Yip G, Khullar K, et al. Propofol for migraine in the emergency department: a pilot randomized controlled trial. Emerg Med Australas. 2020;32(4):542-7. https://doi.org/10.1111/1742-6723.13542

Akgöl Gür ST, Oral Ahiskalioglu E, Aydin ME, Kocak AO, Aydin P, Ahiskalioglu A. Intravenous lidocaine vs NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study. Eur J Clin Pharmacol. 2022;78(1):27-33. https://doi.org/10.1007/s00228-021-03219-5

Lipton RB, Grosberg B, Singer RP, Pearlman SH, Sorrentino JV, Quiring JN, et al. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the international migraine pain assessment clinical trial (IMPACT). Cephalalgia. 2010;30(11):1336-45. https://doi.org/10.1177/0333102410367523

Balbin JEB, Nerenberg R, Baratloo A, Friedman BW. Intravenous fluids for migraine: a post hoc analysis of clinical trial data. Am J Emerg Med. 2016;34(4):713-6. https://doi.org/10.1016/j.ajem.2015.12.080

Harden RN, Gracely RH, Carter T, Warner G. The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department. Headache. 1996;36(6):352-6. https://doi.org/10.1046/j.1526-4610.1996.3606352.x